National Taipei University of Nursing and Health Sciences
Taipei, 112, Taiwan
NCT Number: NCT03161535
This study will investigate the effectiveness of a rehabilitation program in improving sleep quality, emotional distress, circadian rhythms, and quality of life in patients with esophageal cancer in Taiwan.
Hypothesis:
1. The quality of life in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, 24th, and 36th month. 2. The quality of sleep in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, 24th, and 36th month. 3. The emotional distress in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, 24th, and 36th month. 4. The circadian rhythms in exercise group is significant improving than usual-care group at 3rd, 6th, 12th, 24th, and 36th month.
This study is active but is not currently recruiting participants.
20 year and older
All sexes
Interventional
Not applicable
Taipei, 112, Taiwan
This study will investigate the effectiveness of a rehabilitation program in improving sleep quality, emotional distress, circadian rhythms, and quality of life in patients with esophageal cancer in Taiwan.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
For each participant, we discussed exercise regimen-related issues and diet weekly through the telephone. For instance, we discussed whether participants' exercise fulfilled the prescribed intensity, duration, or frequency and whether the participants experienced any adverse effects.
Time frame: baseline
using European Organization for Research and Treatment cancer QLQ-C30 (EORTC) to measure quality of life.
Time frame: 3rd month after recruited
using European Organization for Research and Treatment cancer QLQ-C30 (EORTC) to measure quality of life.
Time frame: 6th month after recruited
using European Organization for Research and Treatment cancer QLQ-C30 (EORTC) to measure quality of life.
Time frame: 12th month after recruited
using European Organization for Research and Treatment cancer QLQ-C30 (EORTC) to measure quality of life.
Time frame: 24th month after recruited
using European Organization for Research and Treatment cancer QLQ-C30 (EORTC) to measure quality of life.
Time frame: 36th month after recruited
using European Organization for Research and Treatment cancer QLQ-C30 (EORTC) to measure quality of life.
Time frame: baseline
using European Organization for Research and Treatment cancer QLQ-OES 18 (EORTC) to measure quality of life.
Time frame: 3rd month after recruited
using European Organization for Research and Treatment cancer QLQ-OES 18 (EORTC) to measure quality of life.
Time frame: 6th month after recruited
using European Organization for Research and Treatment cancer QLQ-OES 18 (EORTC) to measure quality of life.
Time frame: 12th month after recruited
using European Organization for Research and Treatment cancer QLQ-OES 18 (EORTC) to measure quality of life.
Time frame: 24th month after recruited
using European Organization for Research and Treatment cancer QLQ-OES 18 (EORTC) to measure quality of life.
Time frame: 36th month after recruited
using European Organization for Research and Treatment cancer QLQ-OES 18 (EORTC) to measure quality of life.
Time frame: baseline
using Pittsburgh Sleep Quality Index
Time frame: 3rd month after recruited
using Pittsburgh Sleep Quality Index
Time frame: 6th month after recruited
using Pittsburgh Sleep Quality Index
Time frame: 12th month after recruited
using Pittsburgh Sleep Quality Index
Time frame: 24th month after recruited
using Pittsburgh Sleep Quality Index
Time frame: 36th month after recruited
using Pittsburgh Sleep Quality Index
Time frame: baseline
using Actigraph for measure Objective sleep quality
Time frame: 3rd month after recruited
using Actigraph for measure Objective sleep quality
Time frame: 6th month after recruited
using Actigraph for measure Objective sleep quality
Time frame: 12th month after recruited
using Actigraph for measure Objective sleep quality
Time frame: 24th month after recruited
using Actigraph for measure Objective sleep quality
Time frame: 36th month after recruited
using Actigraph for measure Objective sleep quality
Time frame: baseline, 3rd month, 6th month, 12th month, 24th month, and 36th month after recruited
Emotional distress including anxiety and depression (Hospital Anxiety and Depression Scale). The Hospital Anxiety and Depression Scale include anxiety and depression subscales, a total of 7 questions, each subscale is a four-point scoring method, 0 point for "not at all", 3 points for "always do", each subscale scores is between 0 and 21, that a score of 7 or less for non-cases, scores of 8-10 for doubtful cases and scores of 11 or more for definite cases.
Time frame: baseline, 3rd month, 6th month, 12th month, 24th month, and 36th month after recruited
Circadian rhythms including 24-h autocorrelation coefficient (r24) and in bed less than out of bed dichotomy index (I<O) collection from actigraphy.
Time frame: Third month (T2), sixth month (T3), twelfth month (T4), twenty-fourth month (T5), and thirty-sixth month (T6).
Recurrence status was assessed through chart review.
Time frame: Baseline (T1), third month (T2), sixth month (T3), twelfth month (T4), twenty-fourth month (T5), and thirty-sixth month (T6)
Nutritional status, including body weight, Body Mass Index (BMI), and serum albumin level, was assessed through chart review. However, patients will not be required to return to the hospital for blood tests; only existing blood test reports available in the medical records will be retrieved.
Time frame: Third month (T2), sixth month (T3), twelfth month (T4), twenty-fourth month (T5), and thirty-sixth month (T6).
Survival status was assessed through chart review.
Taipei Veterans General Hospital, Taiwan
Other Gov
Effectiveness of a Rehabilitation Program in Improving Sleep Quality, Emotional Distress, Circadian Rhythms, and Quality of Life in Patients With Esophageal Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05891171
Adenocarcinoma, Adnexal Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT04046575
Cancer of the Esophagus, Digestive System Diseases
St Louis, Missouri, United States
View Trial DetailsNCT04400292
Digestive System Diseases, Digestive System Neoplasms
New York, United States
View Trial DetailsNCT07629921
Digestive System Diseases, Digestive System Neoplasms
Shanghai, China
View Trial Details